Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000873252 | SCV001015210 | likely benign | Nemaline myopathy 2 | 2024-08-12 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002478986 | SCV002795347 | likely benign | Nemaline myopathy 2; Arthrogryposis multiplex congenita 6 | 2021-07-07 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000873252 | SCV001457260 | uncertain significance | Nemaline myopathy 2 | 2020-01-24 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004549969 | SCV004771789 | likely benign | NEB-related disorder | 2019-12-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |